OVA mRNAs have been designed to produce high expression level of Ovalbumin protein.
OZ Biosciences mRNAs are produced by in vitro transcription. mRNAs are stabilized at the 5’ end by modified nucleotides capping (Cap1) and contain a poly(A) tail at the 3’ end. Sequences have been optimized to yield improved stability and performance.
OVA mRNAs are also available capped with ExploCap™.
Quality Control:
| Items | Specification | Standard QC | Superior Grade QC* |
|---|---|---|---|
| Appearance | Clear | ✓ | ✓ |
| Integrity | Agarose gel mobility and fragment analyzer | ✓ | ✓ |
| Concentration | 1mg/ml +/- 5% | ✓ | ✓ |
| A260/280 | >1.8 for Unmod, >1.7 for modified | ✓ | ✓ |
| Sterility | Absence of growth | ✓ | ✓ |
| Endotoxin | <0.5 EU/mL | ✓ | |
| dsRNA | <0.5% | ✓ | |
| Functionality | protein expression after transfection | ✓ |
*Our catalogue mRNAs undergo the standard QC. Superior Grade QC can be performed as an additional prestation. Contact us to get a quote.
We recommend using our transfection reagents RmesFect or RmesFect Stem in order to reach high transfection efficiency and optimum protein expression level.
OVA mRNA length: 1375 nt.
Size: 20 µg, 100µg or 1 mg.
Storage: -80°C
Shipping: Dry ice (fee included in shipping cost)
Please log in or register to see the prices for your country
For bulk, please contact us: order@ozbiosciences.com
| Catalog number | Unit Size | Price excl tax | Quantity / Buy |
| MRNA41-20 |
OVA mRNA (5moU) 20µg
|
$184.00
|
|
| MRNA41-100 |
OVA mRNA (5moU) 100µg
|
$350.00
|
|
| MRNA41-1000 |
OVA mRNA (5moU) 1mg
|
$1,878.00
|
|
| MRNA42-20 |
Unmodified OVA mRNA 20µg
|
$176.00
|
|
| MRNA42-100 |
Unmodified OVA mRNA 100µg
|
$282.00
|
|
| MRNA42-1000 |
Unmodified OVA mRNA 1 mg
|
$1,556.00
|
|
| MRNA40-20 |
OVA mRNA (N1-mψ) 20µg
|
$206.00
|
|
| MRNA40-100 |
OVA mRNA (N1-mψ) 100µg
|
$372.00
|
|
| MRNA40-1000 |
OVA mRNA (N1-mψ) 1 mg
|
$1,901.00
|
|
| NAME | MOLECULE VECTOR | PRODUCT | REFERENCE | |
| all cells | 0 | OVA mRNA | Coleman HJ. J Pharm Sci. 2025 Nov 13;115(2):104066. | |
| all cells | 0 | OVA mRNA | Hussain M. RSC Pharma. 2025 doi.org/10.1039/D5PM00150A | |
| all cells | 0 | OVA mRNA | Binici B. Int J Pharm. 2025 Jul 5:682:125941. | |
| all cells | 0 | OVA mRNA | Hussain M. Vaccines 2025 Vaccines 2025 13(4) 370 | |
| all cells | 0 | OVA mRNA | Hassanel DNBP. Int J Pharm. 2024 Sep 15:665:124695. | |
| all cells | 0 | OVA mRNA | Tai JA Vaccines (Basel). 2024 Jul 9;12(7):757. | |
| all cells | 0 | OVA mRNA | Binici B. Vaccines (Basel). 2024 Mar 7;12(3):282. | |
| all cells | 0 | OVA mRNA | Jeger-Madiot R. J Exp Med. 2024 Oct 7;221(10):e20240289. |
Related products